tiprankstipranks
Trending News
More News >
UniDoc Health Corp (TSE:UDOC)
:UDOC

UniDoc Health Corp (UDOC) AI Stock Analysis

Compare
68 Followers

Top Page

TSE:UDOC

UniDoc Health Corp

(UDOC)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
C$0.15
▼(-2.67% Downside)
The score is primarily constrained by very weak financial performance—large losses, significant cash burn, and negative equity. Technicals also lean bearish with the price below all key moving averages and negative MACD, despite oversold signals. Positive corporate developments support commercialization momentum, but are not yet reflected in profitability or cash flow.
Positive Factors
Market Expansion
The installation of H3 Health Cubes in Italy as part of a government-led initiative enhances UniDoc's market reach and positions it as a key player in eHealth, potentially driving long-term growth.
Strategic Partnerships
Partnership with Verizon to showcase Health Cubes in Innovation Labs could expand UniDoc's visibility and credibility in the virtual care market, fostering potential new business opportunities.
Product Recognition
Participation in ANCI 2025 and designation as preferred eHealth equipment in Italy enhances product recognition and aligns with local healthcare priorities, supporting long-term market integration.
Negative Factors
Operating Losses
Significant operating losses relative to revenue indicate a business model that is not yet sustainable, posing a risk to long-term profitability and financial health.
Cash Burn
High cash burn and negative free cash flow suggest ongoing funding challenges, which could limit UniDoc's ability to invest in growth and sustain operations without external financing.
Negative Equity
Negative equity reflects a weak capital structure, increasing financial risk and limiting flexibility, which could constrain UniDoc's ability to navigate economic challenges and invest in growth.

UniDoc Health Corp (UDOC) vs. iShares MSCI Canada ETF (EWC)

UniDoc Health Corp Business Overview & Revenue Model

Company DescriptionUniDoc Health Corp. operates as a virtual health/telemedicine solutions company in Canada. It offers Virtual Health Clinics, a customizable solution that offers safe and secure ways to connect patients in urban, rural, and remote locations with medical care, as well as delivers rapid and real-time diagnostic testing, and supplies therapeutic treatment with continued health monitoring. The company was formerly known as Unicheck Holdings Corp. and changed its name to UniDoc Health Corp. in April 2021. UniDoc Health Corp. was incorporated in 2021 and is based in Vancouver, Canada.
How the Company Makes MoneyUniDoc Health Corp generates revenue primarily through subscription fees for its telemedicine platform, which healthcare providers pay to access the company's suite of digital tools and services. Additionally, the company earns income from licensing its technology to clinics and hospitals, as well as through strategic partnerships with healthcare organizations and insurance companies that integrate UniDoc's solutions into their service offerings. These partnerships often include revenue-sharing agreements, further contributing to UniDoc's earnings. The company may also benefit from government grants and funding initiatives aimed at promoting digital health technologies.

UniDoc Health Corp Financial Statement Overview

Summary
UniDoc Health Corp presents a challenging financial picture with zero revenue generation, negative margins, and consistent losses across income, balance sheet, and cash flow statements. The company's financial health is precarious, with negative equity and poor cash flow ratios indicating financial instability.
Income Statement
UniDoc Health Corp has consistently reported zero revenue, resulting in negative margins across the board. The lack of revenue growth and persistent net losses highlight significant challenges in achieving profitability. The company's negative gross profit and EBIT margins further emphasize the urgent need to generate sales to improve financial health.
Balance Sheet
The company's balance sheet indicates concerning financial instability, with stockholders' equity being negative in several periods. While the debt-to-equity ratio is relatively low due to minimal debt, negative equity and a low equity ratio suggest financial distress and potential solvency issues.
Cash Flow
UniDoc Health Corp's cash flow situation is precarious, with negative free cash flow and operating cash flow ratios indicative of continuous cash burn. The operating cash flow to net income ratio is poor, and the reliance on financing activities to cover cash deficits points to unsustainable operations without strategic changes.
BreakdownTTMDec 2025Dec 2024Dec 2022Dec 2022Dec 2021
Income Statement
Total Revenue458.59K0.000.000.000.000.00
Gross Profit106.44K-37.57K-68.26K-15.25K-64.22K0.00
EBITDA-3.84M-5.93M-2.18M-2.99M-1.28M-237.32K
Net Income-4.05M-6.06M-2.26M-3.00M-1.36M-237.32K
Balance Sheet
Total Assets1.78M2.91M517.08K1.18M320.47K288.40K
Cash, Cash Equivalents and Short-Term Investments344.38K1.25M398.88K854.43K51.32K281.84K
Total Debt47.97K68.68K74.86K79.29K94.79K200.00K
Total Liabilities2.64M2.24M2.38M721.60K1.22M425.13K
Stockholders Equity-857.08K664.52K-1.86M456.28K-900.79K-136.73K
Cash Flow
Free Cash Flow-4.72M-7.66M-559.92K-2.44M-818.36K17.25K
Operating Cash Flow-4.39M-7.40M-559.92K-2.39M-755.59K17.25K
Investing Cash Flow-328.69K-257.76K0.00-51.24K-62.77K0.00
Financing Cash Flow4.70M8.51M907.48K3.01M15.25K264.59K

UniDoc Health Corp Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.15
Price Trends
50DMA
0.18
Negative
100DMA
0.19
Negative
200DMA
0.23
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
46.43
Neutral
STOCH
25.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:UDOC, the sentiment is Neutral. The current price of 0.15 is below the 20-day moving average (MA) of 0.17, below the 50-day MA of 0.18, and below the 200-day MA of 0.23, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 46.43 is Neutral, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:UDOC.

UniDoc Health Corp Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
C$35.65M-7.34-48.53%-9.66%
48
Neutral
C$64.58M-4.36-207.53%7.04%
45
Neutral
C$10.41M-2.7416.04%-455.38%
44
Neutral
C$13.82M-2.7748.94%
42
Neutral
C$8.01M-1.7381.01%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:UDOC
UniDoc Health Corp
0.16
-0.32
-67.01%
TSE:ADK
Diagnos
0.35
<0.01
2.94%
TSE:AIDR
Rocket Doctor AI
0.76
0.14
22.58%
TSE:CHS
Comprehensive Healthcare Systems Inc
0.58
0.38
190.00%
TSE:NARA
PanGenomic Health, Inc. Class A
0.57
0.41
256.25%

UniDoc Health Corp Corporate Events

Business Operations and StrategyProduct-Related Announcements
UniDoc Expands eHealth Footprint with H3 Health Cube Installation in Italy
Positive
Dec 17, 2025

UniDoc Health Corp. has successfully installed its H3 Health Cube in the Guardia Perticara Territorial eHealth Centre in Basilicata, Italy, in collaboration with its regional partner UniCheck SRL. The installation is part of a government-led eHealth initiative geared toward improving accessibility to healthcare services in underserved regions. The adaptable Health Cube was integrated into a historic site and is designed to offer primary care, specialized consultations, and diagnostic support, enhancing healthcare delivery for local communities and reinforcing UniDoc’s position as a key player in eHealth technologies.

Business Operations and StrategyProduct-Related Announcements
UniDoc Health Corp Partners with Verizon to Showcase Health Cubes
Positive
Nov 26, 2025

UniDoc Health Corp has announced the sale and installation of three Health Cubes to Verizon for demonstration purposes within Verizon Innovation Labs. These installations, located in Los Angeles and San Francisco, with a third planned near Washington, D.C., are intended to showcase UniDoc’s virtual care capabilities, including clinician-assisted exams and remote monitoring, to enterprise visitors. This collaboration with Verizon marks a significant step in UniDoc’s commercialization efforts, potentially enhancing its industry positioning by demonstrating its technology to key decision-makers involved in connected care programs.

Business Operations and StrategyProduct-Related Announcements
UniDoc Health Corp to Showcase H3 Health Cube at ANCI 2025 and Extends Marketing Partnership
Positive
Nov 7, 2025

UniDoc Health Corp will exhibit at the 42nd Annual ANCI Assembly in Bologna, Italy, highlighting its H3 Health Cube, which has been designated as preferred eHealth equipment in Italy. This participation aims to engage with municipal leaders to demonstrate the product and align its deployment with local healthcare priorities. Additionally, UniDoc has extended its marketing engagement with Rumble Strip Media Inc. to continue providing social media, marketing, and consulting services, reflecting the company’s strategic efforts to enhance its market presence and stakeholder engagement.

Business Operations and StrategyPrivate Placements and Financing
UniDoc Health Corp Closes $1.5 Million LIFE Offering
Positive
Oct 28, 2025

UniDoc Health Corp has successfully closed its non-brokered private placement LIFE offering, raising $1.5 million through the issuance of 10 million units. The proceeds will be used for inventory, marketing, investor relations, working capital, and general corporate purposes, potentially strengthening the company’s market position and operational capabilities.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025